SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for SYNLOGIC, INC. (SYBX) (CIK 0001527599) (SYBX) — Oct 23, 2017

SYNLOGIC, INC. (SYBX) (CIK 0001527599)
Date: Oct. 23, 2017 · CIK: 0001527599 · Accession: 0000000000-17-037437

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
October 23, 2017
Author
Carlos Gutierrez-Ramos
Form
UPLOAD
Company
SYNLOGIC, INC. (SYBX) (CIK 0001527599)

Letter

October 23, 2017 Carlos Gutierrez-Ramos President and Chief Executive Officer Synlogic, Inc. 200 Sidney Street, Suite 320 Cambridge, MA 02139 Synlogic, Inc. Registration Statement on Form S-3 Filed October 13, 2017 File No. 333-220948Re: Dear Dr. Gutierrez-Ramos: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Christine Westbrook at (202) 551-5019 with any questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Matthew Gardella, Esq.

Show Raw Text
October 23, 2017
Carlos Gutierrez-Ramos
President and Chief Executive Officer
Synlogic, Inc.
200 Sidney Street, Suite 320
Cambridge, MA 02139
Synlogic, Inc.
Registration Statement on Form S-3
Filed October 13, 2017
File No. 333-220948Re:
Dear Dr. Gutierrez-Ramos:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Christine Westbrook at (202) 551-5019 with any questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Matthew Gardella, Esq.